Effect of aldosterone breakthrough on albuminuria during treatment with a direct renin inhibitor and combined effect with a mineralocorticoid receptor antagonist-Reference-Cited by-同舟云学术

Effect of aldosterone breakthrough on albuminuria during treatment with a direct renin inhibitor and combined effect with a mineralocorticoid receptor antagonist

Published:2013-07-18 Issue:10 Volume:36 Page:879-884
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Sato Atsuhisa,Fukuda Seiichi

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

http://www.nature.com/articles/hr201374.pdf

Reference44 articles.

1. Dzau VJ . Theodore Cooper Lecture. Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001; 37: 1047–1052.

2. The Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. Hypertens Res 2009; 32: 1–107.

3. Zaman MA, Oparil S, Calhoun DA . Drugs targeting the renin-angiotensin-aldosterone system. Nat Rev Drug Discov 2002; 1: 621–636.

4. Stanton A, Jensen C, Nussberger J, Obrien E . Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren. Hypertension 2003; 42: 1137–1143.

5. Gradman AH, Schmieder RE, Lins RL, Nussberger J, Chiang Y, Bedigian MP . Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients. Circulation 2005; 111: 1012–1028.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of the Risk Factors and Management of Refractory Hypertension: The Role of Carotid Sinus Stimulation and Renal Nerve Denervationhypertension, resistant, resistant hypertension, hypertension treatment, nerve ablation, treatment resistant hypertension, carotid sinus stimulation;Journal of Community Hospital Internal Medicine Perspectives;2024-07-02

2. Evolution of Mineralocorticoid Receptor Antagonists in the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes Mellitus;Mayo Clinic Proceedings: Innovations, Quality & Outcomes;2022-12

3. Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy;BMC Complementary Medicine and Therapies;2022-08-06

4. Aldosterone breakthrough from a pharmacological perspective;Hypertension Research;2022-04-14

5. Effects of mineralocorticoid receptor antagonists on sex hormones and body composition in patients with primary aldosteronism;Hypertension Research;2021-12-27